US drug giant Pfizer and its German partner BioNTech have applied for emergency authorization for their coronavirus vaccine in the United States. The vaccine has performed well in initial safety trials, and the US Food and Drug Administration could grant permission before testing is complete. If it does, the first doses could be administered next month. For many people, the severe health and economic impacts of the pandemic mean a vaccine can’t come soon enough.
Will enough people get vaccinated to stop spread of Covid? | DW News
